Financial Daily from THE HINDU group of publications
Wednesday, Aug 25, 2004
Financial Daily from THE HINDU group of publications Wednesday, Aug 25, 2004 |
||
|
|
||
|
Corporate
-
Announcements Ranbaxy gets FDA nod to make, market Loratadine Syrup Our Bureau
New Delhi , Aug. 24 RANBAXY Laboratories Ltd (RLL) has received approval from the US Food and Drug Administration (FDA) to manufacture and market Loratadine Syrup that is available to patients as an over-the-counter (OTC) product. Basically an anti-allergy drug, Loratadine is indicated for the temporary relief of nasal and non-nasal symptoms of seasonal allergic rhinitis and for the treatment of chronic idiopathic urticaria in patients two years of age or older. "We are now in a position to be able to offer an additional dosage form of this non-drowsy antihistamine that is available to patients as an OTC product. It will be available in September to all private label customers that consists of drug chains, independent retail outlets, mass merchandisers, food combination outlets, and wholesalers," said Mr Sandeep Parekh, Vice-President of Sales and Marketing for Ohm. Ohm is a wholly-owned subsidiary of RLL engaged in the sale and distribution of generic and branded private label, OTC products to the US healthcare system.
More Stories on : Announcements | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
Stories in this Section |
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2004, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|